In summary, our study demonstrates that podocyte-derived FGF4 activates the FGFR1-AMPK-FOXO1 signaling pathway to mitigate oxidative stress and promote podocyte survival, thereby preserving glomerular integrity and protecting the kidney from diabetes-induced injury. Here, FOXO1 is linked to diabetes mellitus.